ACW Ann: Actinogen Alzheimer Disease Biomarker Study Timing & Design - 13th Jul 2022, 10:05am

annb0t

annb0t

Top 20
ACW Ann: Actinogen Alzheimer Disease Biomarker Study Timing & Design
Price Sensitive: N
Date: 13th Jul 2022, 10:05am

>>> Read announcement: Google: ACW Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
ACW Ann: Amendment to Actinogen 2023 AGM resolutions 6 to 10 - 27th Oct 2023, 1:59pm
Replies
0
Views
160
annb0t
annb0t
annb0t
ACW Ann: Actinogen September quarterly activity report & Appendix 4C - 16th Oct 2023, 9:31am
Replies
0
Views
130
annb0t
annb0t
annb0t
ACW Ann: Actinogen enhances XanaMIA Phase 2b Alzheimers trial - 26th Sep 2023, 9:46am
Replies
0
Views
132
annb0t
annb0t
annb0t
ACW Ann: Actinogen closes successful $10 million rights issue offer - 7th Sep 2023, 10:12am
Replies
0
Views
151
annb0t
annb0t
annb0t
ACW Ann: Actinogen FY2023 results, following the science - 30th Aug 2023, 7:04pm
Replies
0
Views
154
annb0t
annb0t
Top Bottom